Home › Small Cell Lung Cancer › Alabama › Mobile
Small Cell Lung Cancer clinical trials in Mobile, AL
6 studies for Small Cell Lung Cancer are looking for participants at sites in and around Mobile (within about 30 miles). Open a study to see who can join and how to contact the study team.
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
RecruitingPhase 3
- Infirmary Cancer Care, Mobile
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
RecruitingPhase 3
- Usa Mitchell Cancer Institute /ID# 280198, Mobile
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
RecruitingPhase 3
- Southern Cancer Center, PC, Daphne · 10 mi away
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
RecruitingPhase 2
- Southern Cancer Center, Daphne · 10 mi away
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
RecruitingPhase 2
- Infirmary Cancer Care, Mobile
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Recruiting
- University of South Alabama, Mobile
Small Cell Lung Cancer trials in other cities
- Houston, TX26 studies
- Arlington, VA23 studies
- Boston, MA21 studies
- New York City, NY21 studies
- Nashville, TN20 studies
- Los Angeles, CA20 studies
- Orlando, FL15 studies
- St. Louis, MO13 studies
- Cleveland, OH13 studies
- Dallas, TX13 studies
- Detroit, MI12 studies
- Chicago, IL12 studies
Other studies in Mobile
- Heart Failure13 studies
- Non-Small Cell Lung Cancer13 studies
- Obesity7 studies
- Breast Cancer7 studies
- Lung Cancer7 studies
- Ovarian Cancer7 studies
- Cardiovascular Disease6 studies
- Melanoma6 studies
- Cancer (all types)6 studies
- Atrial Fibrillation5 studies
- Type 2 Diabetes5 studies
- Crohn's Disease5 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.